Health and beauty product maker Colgate-Palmolive has announced that its first-quarter sales were below expectations, as demand for its products slumped in emerging markets.
Excluding some items, Colgate earned 74 United States cents per share, above analysts' average estimate of 72 cents. Jefferies Group reaffirmed a "hold" rating and set a $79.00 price target on shares of Colgate-Palmolive in a research report on Friday, January 26th. Argent invested 0.31% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Zacks Investment Research upgraded Colgate-Palmolive from a "sell" rating to a "hold" rating in a research report on Tuesday, April 17th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the company's stock. Colgate-Palmolive now has a consensus rating of "Hold" and an average price target of $77.69. The 52-week high of the stock is now $77.91 while its 52-weeks low stands at $65.85.
Colgate-Palmolive Company (NYSE:CL) gained 0.27% with the closing price of $66.59. The hedge fund run by Frank Brosens held 65,000 shares of the package goods and cosmetics company at the end of 2017Q4, valued at $4.90M, down from 75,000 at the end of the previous reported quarter. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The business had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. The Pdt Partners Llc holds 143,703 shares with $3.72M value, up from 59,393 last quarter.
CL is reaching $66.81 during the last trading session, after increased 0.33%.Colgate-Palmolive Company has volume of 1.91M shares. Also, Vice Chairman Franck J. Moison sold 142,979 shares of the business's stock in a transaction on Tuesday, February 6th. In Friday, April 20 report Morgan Stanley maintained the stock with "Overweight" rating.
The current market cap of Colgate-Palmolive Company is valued at $62.09B. Let's take a quick look at some other time spans, the 12 months price index reads 1.7, the 24 month is 2.73. The ex-dividend date of this dividend is Thursday, April 19th. The ratio worsened due to Colgate-Palmolive Company positioning: 56 sold and 444 reduced.
Colgate-Palmolive (NYSE:CL) insider Daniel B. Marsili sold 19,500 shares of Colgate-Palmolive stock in a transaction on Monday, April 16th. Citadel Advsrs Ltd invested in 10,486 shares or 0% of the stock. (NASDAQ:ORIT) by 23,080 shares to 15,169 shares, valued at $248,000 in 2017Q4, according to the filing. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The shares were sold at an average price of $74.12, for a total value of $346,585.12. The disclosure for this sale can be found here. Also, Director Ellen M. Hancock sold 4,676 shares of the company's stock in a transaction dated Wednesday, January 31st. Virtue Capital Management LLC purchased a new position in Colgate-Palmolive during the fourth quarter valued at approximately $104,000. Certified Advisory Corp acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $143,000. $396,561 worth of Colgate-Palmolive Company (NYSE:CL) shs were sold by HICKEY DENNIS J. The insider Daniels Jennifer sold $68,390. The institutional investor held 126,112 shares of the company at the end of 2017Q4, valued at $2.40M, down from 144,759 at the end of the previous reported quarter. To ascertain 10-Months Price Index, simply dividing current price of the stock by the 10-Months back price. Finally, Commonwealth Bank of Australia increased its position in shares of Colgate-Palmolive by 11.8% during the third quarter. Commonwealth Bank of Australia now owns 634,577 shares of the company's stock valued at $45,997,000 after buying an additional 67,213 shares during the period. Institutional investors own 73.63% of the company's stock. Alpha Windward Ltd Liability has invested 0.13% in Colgate-Palmolive Company (NYSE:CL). The firm offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches, and other related products.
A Look at Target Price and Valuation of Geron Corporation (GERN)
The earnings growth rate for the next years is an important measure for investors planning to hold onto a stock for several years. The 50-day moving average is perceived to be the dividing line between a stock that is technically healthy and one that is not.
On May, 9 Heron Therapeutics, Inc. (HRTX) EPS Estimated At $
Leverage ratio is the total debt of a company divided by total assets of the current and past year divided by two. (NASDAQ:PLCE). The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital.